United States · FDA National Drug Code directory
SODIUM PHOSPHATES
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-730_c968f70b-a670-4aef-a7e0-89468ad62d9c
- Product NDC
- 68462-730
- Form
- INJECTION, SOLUTION
- Composition / generic term
- SODIUM PHOSPHATES
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260223
- Source listing expiry
- 20271231
Source-listed ingredients
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE — 276 mg/mL
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE — 268 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, SINGLE-DOSE in 1 CARTON (68462-730-25) / 50 mL in 1 VIAL, SINGLE-DOSE (68462-730-50) · 68462-730-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →